Agilent Technologies, Inc. provides application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Agilent's life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. The Company's diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses.
Type
Public
HQ
Santa Clara, US
Founded
1999
Size (employees)
13,500 (est)+2%
Agilent Technologies was founded in 1999 and is headquartered in Santa Clara, US
Report incorrect company information

Key People/Management at Agilent Technologies

Mike McMullen

Mike McMullen

President and Chief Executive Officer
Didier Hirsch

Didier Hirsch

Senior Vice President, Chief Financial Officer
Darlene Solomon

Darlene Solomon

Senior Vice President, Chief Technology Officer

Agilent Technologies Office Locations

Agilent Technologies has an office in Santa Clara
Santa Clara, US (HQ)
5301 Stevens Creek Blvd
Show all (1)
Report incorrect company information

Agilent Technologies Financials and Metrics

Agilent Technologies Financials

Agilent Technologies's revenue was reported to be $4.47 b in FY, 2017
USD

Revenue (Q2, 2018)

2.4 b

Net income (Q2, 2018)

(115 m)

EBIT (Q2, 2018)

454 m

Market capitalization (14-Jun-2018)

21.2 b

Closing share price (14-Jun-2018)

66.3

Cash (30-Apr-2018)

3 b

EV

20 b
Agilent Technologies's current market capitalization is $21.2 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

6.8 b7 b4 b4.2 b4.5 b

Revenue growth, %

3%(42%)4%

Cost of goods sold

3.2 b3.4 b2 b2 b

Gross profit

3.5 b3.6 b2 b2.2 b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

1.7 b1.7 b1.8 b1 b963 m1 b1 b1 b1 b1.1 b1.1 b1.1 b1.2 b2.4 b

General and administrative expense

488 m513 m508 m310 m292 m290 m304 m318 m310 m289 m307 m308 m341 m679 m

R&D expense

177 m176 m177 m88 m81 m79 m78 m81 m86 m79 m84 m87 m93 m184 m

Operating expense total

1.5 b1.5 b1.5 b911 m856 m870 m873 m888 m898 m861 m901 m913 m972 m2 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.7 b3 b2 b2.3 b2.7 b

Accounts Receivable

899 m983 m606 m631 m724 m

Inventories

1.1 b1.1 b541 m533 m575 m

Current Assets

5 b5.5 b3.7 b3.6 b4.2 b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

2.7 b3 b2.4 b2.1 b2.2 b2.1 b1.9 b2.1 b2.2 b2.2 b2.4 b2.6 b2.9 b3 b

Accounts Receivable

849 m903 m891 m615 m576 m584 m617 m602 m590 m653 m677 m678 m751 m754 m

Inventories

1.1 b1.1 b1.1 b560 m556 m545 m554 m555 m543 m551 m548 m566 m608 m594 m

Current Assets

5.1 b5.4 b4.8 b3.7 b3.6 b3.5 b3.4 b3.5 b3.5 b3.6 b3.8 b4 b4.4 b4.5 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

724 m504 m401 m462 m684 m

Depreciation and Amortization

372 m384 m253 m246 m212 m

Inventories

(100 m)(99 m)(24 m)(7 m)(61 m)

Accounts Payable

(27 m)50 m(26 m)(15 m)2 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

195 m139 m147 m72 m83 m103 m123 m91 m124 m168 m332 m507 m(320 m)(115 m)

Depreciation and Amortization

55 m109 m160 m51 m101 m

Inventories

545 m554 m555 m543 m(26 m)(29 m)(46 m)(34 m)(34 m)

Accounts Payable

248 m250 m220 m261 m9 m6 m11 m(3 m)(14 m)
USDY, 2018

EV/EBIT

44.1 x

EV/CFO

38.6 x

Financial Leverage

1.9 x
Show all financial metrics

Agilent Technologies Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Advanced Analytical Technologies (70)March 07, 2018$250 m

Agilent Technologies Revenue Breakdown

Embed Graph

Agilent Technologies revenue breakdown by business segment: 33.8% from Agilent CrossLab, 16.9% from Diagnostics and Genomics and 49.3% from Life Sciences and Applied Markets

Report incorrect company information

Agilent Technologies Online and Social Media Presence

Embed Graph
Report incorrect company information

Agilent Technologies News and Updates

Anatomic Pathology Market increasing demand with Leading key players: Agilent Technologies, Inc., Bio SB, Biogenex Laboratories, Danaher Corporation

HTF MI published a new industry research that focuses on Anatomic Pathology market and delivers in-depth market analysis and future prospects of Global Anatomic Pathology market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry exp…

Wireless Gas Detection System Market is touching new level with leading key players Agilent Technologies, Danaher Corporation, TE Connectivity

A new independent 118 page research with title 'World Wireless Gas Detection System Market Research Report 2022(Covering USA, EU, China, South East Asia, India, Japan and etc)'  guarantees you will remain better informed than your competition. Posted via Industry Today. Follow us on Twitter @Indust…

$6,443.5 million Growth Opportunities for the Molecular Spectroscopy Worldwide Market 2017-2024 with Top Key Players Thermofisher Scientific and Agilent Technologies

First time buyer? check offers and get avail 10% discount on Customize Report of “Global Molecular Spectroscopy Market” Also Available On Request (As per Requirement) Or kindly send the email at sopan.gedam@databridgemarketresearch.com Posted via Industry Today. Follow us on Twitter @IndustryToday

Protein Crystallization and Crystallography Market Outlook to 2025 by Agilent Technologies, Mitegen, Anton Paar

The Insight Partners has announced the addition of the “Protein Crystallization and Crystallography Market 2025 – Global Analysis and Forecasts by Technology (Ion Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR and X-Ray Crystallography); Products (Reagents and Instruments) & End-Users (…
Show more
Report incorrect company information